GURUFOCUS.COM » STOCK LIST » Canada » XCNQ » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Accumulated other comprehensive income (loss)
Switch to:

Entheon Biomedical (XCNQ:ENBI) Accumulated other comprehensive income (loss)

: C$2.87 Mil (As of Nov. 2022)
View and export this data going back to 2018. Start your Free Trial

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Entheon Biomedical's Accumulated other comprehensive income (loss) for the quarter that ended in Nov. 2022 was C$2.87 Mil.

Entheon Biomedical's quarterly Accumulated other comprehensive income (loss) declined from May. 2022 (C$3.60 Mil) to Aug. 2022 (C$3.50 Mil) and declined from Aug. 2022 (C$3.50 Mil) to Nov. 2022 (C$2.87 Mil).

Entheon Biomedical's annual Accumulated other comprehensive income (loss) increased from Mar. 2020 (C$0.00 Mil) to Nov. 2021 (C$3.24 Mil) but then declined from Nov. 2021 (C$3.24 Mil) to Nov. 2022 (C$2.87 Mil).

Entheon Biomedical Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Entheon Biomedical's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22
Accumulated other comprehensive income (loss)
Premium Member Only - - - 3.24 2.87

Entheon Biomedical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Accumulated other comprehensive income (loss) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.41 3.60 3.50 2.87

Entheon Biomedical Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Entheon Biomedical Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Entheon Biomedical logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
TSXV:VXL TSXV:WAVE XCNQ:MYND TSXV:MRVL TSX:IPCI XCNQ:WESA TSXV:RP TSXV:NSP XCNQ:TRYP TSXV:PAS OCSE:NOVO B ASX:CSL NAS:REGN NAS:VRTX NAS:MRNA XKRX:207940 NAS:BNTX HKSE:02269 NAS:SGEN SZSE:300122
Traded in Other Exchanges
ENTBF:USA 1XU1:Germany
Address
999 W Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Website
https://www.entheonbiomedical.com
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines